Major vault protein regulates class A scavenger receptor-mediated tumor necrosis factor-α synthesis and apoptosis in

Jingjing Ben1, Yan Zhang, Rongmei Zhou

  • 1Atherosclerosis Research Center, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing 210029, China.

Insights

Major vault protein (MVP) interacts with scavenger receptor A (SR-A) on macrophages, modulating inflammatory responses and apoptosis. This discovery offers new insights into atherosclerosis development and potential therapeutic targets.

Area of Science:

  • Immunology
  • Cell Biology
  • Cardiovascular Research

Background:

  • Atherosclerosis is a chronic inflammatory disease driven by macrophage-derived pro-inflammatory mediators.
  • Scavenger receptor A (SR-A) on macrophages is crucial, but its regulatory mechanisms are unclear.

Purpose of the Study:

  • To identify novel binding partners of SR-A in macrophages.
  • To elucidate the role of SR-A and its interacting proteins in macrophage-mediated inflammation and apoptosis relevant to atherosclerosis.

Main Methods:

  • Immunoprecipitation coupled with mass spectrometry to identify SR-A binding partners.
  • Immunofluorescence staining and chemical cross-linking to confirm protein interactions.
  • Macrophage stimulation with fucoidan (SR-A ligand) and assessment of TNF-α production.
  • Analysis of endocytic pathways (caveolin- vs. clathrin-mediated) and signaling pathways (p38, JNK, ERK).
  • Investigation of MVP localization in lipid rafts and its effect on SR-A-mediated apoptosis.

Main Results:

  • Major vault protein (MVP) was identified as a novel binding partner of SR-A.
  • MVP depletion attenuated fucoidan-induced TNF-α production in macrophages.
  • SR-A-mediated TNF-α synthesis involves caveolin-dependent endocytosis and p38/JNK signaling.
  • MVP enrichment in lipid rafts enhances SR-A, caveolin, and MVP interactions.
  • MVP elimination reduced SR-A-mediated macrophage apoptosis.

Conclusions:

  • MVP fine-tunes SR-A activity in macrophages, influencing pro-inflammatory responses and apoptosis.
  • The SR-A-MVP interaction represents a potential regulatory axis in atherosclerosis pathogenesis.
  • Targeting the SR-A-MVP pathway may offer novel therapeutic strategies for atherosclerosis.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...